Utama › Kanser Kolon › Illinois
Kajian klinikal Kanser Kolon di Illinois
18 kajian untuk Kanser Kolon sedang mencari peserta di lokasi di Illinois.
Bandar di Illinois
- Chicago14 kajian
- Arlington Heights6 kajian
- Waukegan5 kajian
- Cicero5 kajian
- Evanston5 kajian
- Naperville5 kajian
- Joliet4 kajian
- Springfield4 kajian
- Carbondale4 kajian
- Peoria4 kajian
- Bloomington4 kajian
- Champaign4 kajian
- Galesburg4 kajian
- North Peoria4 kajian
- Rockford3 kajian
- Aurora3 kajian
- Danville3 kajian
- Decatur3 kajian
- Charleston3 kajian
Teks kajian rasmi (Bahasa Inggeris)
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
- OSF Saint Anthony's Health Center, Alton
- Illinois CancerCare-Bloomington, Bloomington
- Illinois CancerCare-Canton, Canton
- dan 31 lagi
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07283939Family Communications After Genetic Testing
- OSF Saint Anthony's Health Center, Alton
- Advocate Outpatient Center - Aurora, Aurora
- Advocate Good Shepherd Hospital, Barrington
- dan 46 lagi
Mengambil pesertaSukarelawan sihat dialu-alukan
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT07143487A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
- Endeavor Health ( Site 2027), Evanston
- Accellacare of Duly ( Site 2015), Lisle
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT06997497PRE-ISPY Phase I/II Oncology Platform Program
- The University of Chicago Medicine Comprehensive Cancer Center, Chicago
- UChicago Medicine Comprehensive Cancer Center at Silver Cross Hospital, New Lenox
- UChicago Medicine Orland Park, Orland Park
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 30 Sep 2026 · NCT05868226Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
- Illinois Cancer Specialists, Arlington Heights
- Illinois CancerCare - Bloomington, Bloomington
- Illinois Cancer Specialists, Chicago
- dan 10 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07222800A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
- Sih Cancer Institute, Carterville
- University of Illinois Cancer Center, Chicago
- Alexian Brothers Medical Center, Elk Grove Village
- dan 2 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 15 Sep 2026 · NCT07284849Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
- OSF Saint Anthony's Health Center, Alton
- John H Stroger Jr Hospital of Cook County, Chicago
- Loyola University Medical Center, Maywood
- dan 3 lagi
Mengambil peserta
Umur 45 hingga 70 · Semua jantina · Dikemas kini 2 Sep 2026 · NCT05080673Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
- OSF Saint Anthony's Health Center, Alton
- Rush-Copley Medical Center, Aurora
- Advocate Outpatient Center - Aurora, Aurora
- dan 73 lagi
Mengambil pesertaFasa 2/3
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Sep 2026 · NCT05174169BMS-986504 in Combination With Pemetrexed for the Treatment of Metastatic Solid Tumors With MTAP Deletion
- Northwestern University, Chicago
Mengambil pesertaFasa 1/2
Umur 18 ke atas · Semua jantina · Dikemas kini 25 Ogo 2026 · NCT07594626Shield Post-Approval Study Protocol
- Digestive Disease Consultants, Bourbonnais
- Digestive Disease Consultants, Bourbonnais
- Christie Clinic, Champaign
- dan 9 lagi
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 45 hingga 81 · Semua jantina · Dikemas kini 7 Ogo 2026 · NCT06880055Study of XmAb®819 in Subjects With Advanced Clear Cell Renal Cell Carcinoma
- Xencor Investigative Site, Chicago
- Xencor Investigative Site, Chicago
Mengambil pesertaFasa 1
Umur 18 ke atas · Semua jantina · Dikemas kini 3 Ogo 2026 · NCT05433142Neoadjuvant Botensilimab and Balstilimab for the Treatment of Advanced Resectable Colorectal Cancer NEST3
- City of Hope at Illinois Chicago Downtown, Chicago
- City of Hope at Chicago, Zion
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Jul 2026 · NCT07595874Integrated Cancer Repository for Cancer Research
- Rush-Copley Cancer Care Center, Aurora
- Rush-Copley Healthcare Center, Yorkville
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 19 hingga 110 · Semua jantina · Dikemas kini 29 Jun 2026 · NCT02012699A Study of Fruquintinib Plus FOLFIRI as Second-Line Treatment for Participants With Metastatic Colorectal Cancer (FRUITFUL)
- Illinois Cancer Specialists, Arlington Heights
Mengambil pesertaFasa 2
Umur 18 ke atas · Semua jantina · Dikemas kini 12 Jun 2026 · NCT07011576A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
- University of Chicago, Chicago
Mengambil pesertaFasa 1/2
Umur 12 ke atas · Semua jantina · Dikemas kini 27 Mei 2026 · NCT03093116Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer
- Section of Gastroenterology, Hepatology, and Nutrition, Department of Medicine University of Chicago Medicine, Chicago
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
Umur 18 hingga 49 · Semua jantina · Dikemas kini 24 Apr 2026 · NCT05732623Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
- GSK Investigational Site, Chicago
- GSK Investigational Site, Chicago
- GSK Investigational Site, Naperville
- dan 1 lagi
Mengambil pesertaFasa 3
Umur 18 ke atas · Semua jantina · Dikemas kini 23 Jan 2026 · NCT05855200SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Chicago
Mengambil pesertaKajian pemerhatian
Semua umur · Semua jantina · Dikemas kini 28 Okt 2025 · NCT03452774Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.